Improving DNA-Based Therapies
An innovative platform that expands the scope of genetic treatments by combining unprecedented DNA optimization with non-viral delivery. The company develops advanced drugs that deliver the correct genes to patients with a mutated gene causing a rare disease or disorder.
CEO
Guillaume Madec
WEBSITE
https://tyristx.com/
INVESTED COMPANY
2021
DETAILS
Tyris TX
Ronda Narciso Monturiol, 17 A
Paterna Technology Park, 46980 Valencia, Spain
